Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Liyan Wang
Introduction
Liyan Wang is a notable inventor based in Shenzhen, China. He has made significant strides in the field of cancer research, particularly with his innovative approach to anticancer agents. His work focuses on developing treatments for cancers characterized by elevated levels of cyclin D1 protein.
Latest Patents
Liyan Wang holds a patent for an anticancer agent that targets cancers with a higher abundance of cyclin D1 protein compared to control levels. The patent describes a compound represented by a specific formula, which includes active ingredients that can be aliphatic groups or other specified chemical structures. This innovative approach has the potential to provide new avenues for cancer treatment.
Career Highlights
Throughout his career, Liyan Wang has demonstrated a commitment to advancing medical science through his inventions. His patent reflects his dedication to addressing critical health challenges and improving patient outcomes. His work is a testament to the importance of innovation in the medical field.
Collaborations
Liyan Wang has collaborated with esteemed colleagues such as Shohei Miyata and Susumu Kitanaka. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in driving innovation.
Conclusion
Liyan Wang's contributions to cancer research through his patented anticancer agent exemplify the impact of innovation in medicine. His work not only showcases his expertise but also holds promise for future advancements in cancer treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.